IMMX
Immix Biopharma Inc
NASDAQ: IMMX · HEALTHCARE · BIOTECHNOLOGY
$8.93
+3.48% today
Updated 2026-04-30
Market cap
$505.20M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.89
Dividend yield
—
52W range
$2 – $12
Volume
0.7M
Immix Biopharma Inc (IMMX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-790032.00 | $-404694.00 | $-1.59M | $-7.41M | $-11.37M | $-14.60M | $-23.93M |
| Capital expenditures | $7308.00 | $4.00 | $802.00 | $0.00 | $52089.00 | $1.18M | $732925.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | — | $0.00 | $218983.00 | $624069.00 | $2.57M | $3.02M | $2.44M |
| Free cash flow | $-797340.00 | $-404698.00 | $-1.59M | $-7.41M | $-11.42M | $-15.77M | $-24.66M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |